Pes Camanchaca (CAMANCHACA)
Santiago Stock Exchange · Chile · prices in CLP · close of 27 Oct 2026
Key indicators
| Last close | CLP 93.00 |
|---|---|
| 52-week range | 24.50 – 96.88 |
| Return, 1 month / 3 months | +13.4% / +29.2% |
| Return, 1 year / 3 years | +54.9% / +108.7% |
| Trend | Uptrend |
| RSI (14) | 88 |
| Volatility (1 year) | 23.9% |
| Worst drawdown (1 year) | -27.8% |
| Average daily value traded | 210.44M CLP |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pes Camanchaca is a Chilean seafood company based in Puerto Montt that farms and processes Atlantic salmon and harvests mussels and other shellfish. It operates salmon farming and processing facilities in southern Chile and sells fresh and frozen seafood products, mainly to export markets in Asia, North America and Europe. Its customers include seafood distributors, retailers and food service businesses that buy salmon fillets, portions and shellfish products.
Pes Camanchaca trades under the code CAMANCHACA on the Santiago Stock Exchange in Chile, with its price quoted in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pes Camanchaca (CAMANCHACA) trades on the Santiago Stock Exchange in Chile. It last closed at CLP 93.00 on 27 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 39 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 54.9% and over the last three months it rose 29.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Santiago Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 15.2% | ||
| From 52-week high | -2.9% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 29.2% | ||
| 6-month return | 10.2% | ||
| 12-month return, skipping the last month | 36.6% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.8% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 210.44M CLP | ||
| Zero-volume days | 8.3% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +10.7% |
|---|---|
| 1 month | +13.4% |
| 3 months | +29.2% |
| 6 months | +10.2% |
| 1 year | +54.9% |
| 3 years | +108.7% |
| 5 years | +227.4% |
Signals
| 50-day / 200-day average | 78.43 / 80.75 |
|---|---|
| Golden / death cross (60 days) | Death, 51 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.19 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | CLP 2.6520 |
| 5 May 2025 | CLP 1.2785 |
| 3 May 2024 | CLP 0.6507 |
| 5 May 2023 | CLP 2.0310 |
| 5 May 2022 | CLP 2.0640 |
| 8 May 2020 | CLP 2.0683 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Santiago Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.